Skip to main content

Advertisement

Table 2 Hemodynamic measurements, elastography, laboratory findings, chemotherapy, SOS, and complications

From: Changes of liver hemodynamic and elastography parameters in patients with colorectal liver metastases receiving preoperative chemotherapy: “a note of caution”

Patient HVPG Elastography Platelets PT (%) Chemotherapy (cycles) OBC SOS Complications
1 4.50 6.80 336,000 100 FOLFOX [6] Yes Yes 0
2 6.50 N/A 157,000 100 FOLFOX [8] Yes Yes I
3 2.00 N/A 135,000 76 Capecitabine [2] 0
4 4.00 N/A 105,000 98 FOLFOX [9] Yes I
5 7.00 7.90 150,000 95 FOLFOXIRI [8] Yes Yes IIIA
6 6.00 8.40 136,000 89 FOLFOX [6] Yes Yes IIIA
7 2.00 N/A 196,000 99 FOLFOX + FOLFIRI [12] I
8 2.50 3.80 192,000 100 FOLFOX [4] Yes I
9 2.50 4.70 199,000 100 Capecitabine [1] 0
10 1.50 N/A 197,000 100 FOLFOX + bevacizumab [7] I
11 5.00 N/A 191,000 100 FOLFOX [4] Yes Yes IIIB
12 2.50 5.20 274,000 100 Capecitabine [6] 0
13 4.00 4.40 157,000 100 FOLFOX [5] Yes Yes IIB
14 4.00 6.10 135,000 100 FOLFOX [3] I
15 4.00 7.60 283,000 100 FOLFOX [6] Yes I
16 2.50 3.60 215,000 92 FOLFIRI + cetuximab [6] I
17 6.00 4.50 291,000 78 TOMOX [6] Yes Yes IIIA
18 2.00 5.20 157,000 100 FOLFOX + TOMOX + panitumumab [8] 0
19 4.5 4.00 331,000 100 FOLFOX [5] Yes Yes 0
20 3 3.50 335,000 62.50 XELOX [5] Yes IIIB
  1. N/A not available